In addition to increased p53 expression, Abdulamir et al reported more frequent expression of BCL-2, c-myc, and Rb in bladder biopsy specimens in Sh-associated bladder cancer in Jordan and Syria [179]. The gene discussed is BCL2; the disease is urinary bladder carcinoma.